PubMed Health⌕ Search

PubMed · 10897825

[High-frequency thermocoagulation. Use in bronchial endoscopy].

Abstract

High frequency thermocoagulation is a relatively recent technique of destroying tracheobronchial tumour mass. It selects the thermal effect of electrical current whilst avoiding the electrolytic and faradic effects of nerve and muscle stimulation. With gentle coagulation which is generally utilised the tissues are heated to between 70 and 100 degrees with the formation of water vapour and immediate destruction of the tissues. The electrodes are usually unipolar and are either rigid or flexible. The HF current which circulates across the tissues is gathered and evacuated by neutral electrodes. A new generation of fiberoptic bronchoscopes which isolate the exit current may optimise the safety of the procedure. New generators delivering a stable voltage controlled by a microprocessor enable the control of the process of coagulation and adapt the thermal energy delivered to the volume and nature of the tissue to be destroyed. The electrode is put in contact with the tissues. The immediate effects is similar to those described with laser. The simplicity, speed of utilization, minimal morbidity and relatively low cost has made this an interesting technique even in developed countries where the investment budgets are becoming more and more limited.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J P Homasson. 1999. [High-frequency thermocoagulation. Use in bronchial endoscopy].. https://pubmed.ncbi.nlm.nih.gov/10897825/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Malignant disease in peptic ulcer surgery patients after long term follow-up: a cohort study of 1992 patients.

AIMS: To assess the effect of previous peptic ulcer surgery on subsequent malignant events, in particular in relation to previous vagotomy, a historical cohort study was conducted. METHODS: All patients undergoing surgery for peptic ulcer disease with accurate follow-up data at a large peptic ulcer clinic in the Western Infirmary, Glasgow, from 1965 to 1983 were assessed. All cancer events and specific cancer events (gastric, bronchial, laryngeal, colorectal, bladder, breast, prostate, pancreas, kidney, oesophageal cancers) were determined as outcome measures and expressed as standardised incidence ratio (SIR). RESULTS: Vagotomy and drainage accounted for 67% of all procedures for peptic ulcer disease. Eighty-three percent were habitual smokers. For all peptic ulcer surgery patients, the SIR for all cancer events was 0.86. For specific cancers, the SIRs were bronchial cancer (SIR 1.13); laryngeal cancer (SIR 2.17), colorectal cancer (SIR 0.67). For vagotomised patients the risk of gastric cancer was significantly elevated (SIR 1.50). CONCLUSIONS: An excess of cancers attributable to smoking have been found in peptic ulcer surgery patients. Vagotomised patients have a higher risk of gastric cancer after long term follow-up. This finding may have implications for screening and the safety of long term acid suppression with agents such as proton pump inhibitors.

Bronchial Neoplasms↗

CT/MRI of neuroendocrine tumours.

Neuroendocrine tumours (NETs) are often thought to be rare and rather recherché cancers which are of little concern to the general physician, surgeon or radiologist because of their rarity and esoteric nature. In fact, while relatively uncommon, the total group of gastro-entero-pancreatic (GEP) tumours incorporates the spectrum of all types of carcinoids, including bronchial carcinoids, and the whole gamut of islet-cell tumours. Some of these may present as functioning tumours, with a plethora of hormonal secretions and concomitant clinical syndromes, and GEPs in general have an incidence around 30 per million population per year. This means that in the whole European Union, for example, there will be in the region of 12,000 new patients every year presenting with one or another manifestation of these tumours. Furthermore, the comparatively long survival of many of these patients, compared to more common adenocarcinomas or epithelial tumours, implies that the point prevalence is also not inconsiderable. However, it is undoubtedly true that these tumours can be difficult to identify, especially in their early stages, and it is then that radiological investigation becomes of paramount importance. Having taken into account all these considerations, most investigators would initiate investigation of a suspected or biochemically proven islet-cell tumour with cross-sectional imaging-either CT or MRI. This will clearly identify the larger lesions, allow assessment of the entire abdomen, and provide valuable information on the presence of hepatic metastates.

Bronchial Neoplasms↗